Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-12-02

FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for a generic risperidone version manufactured by Torrent Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)